Clinical Trial Update: GHB Withdrawal Symptoms and Effectiveness of Treatment With Lorazepam Versus Pentobarbital - 1 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating lorazepam versus pentobarbital for GHB withdrawal symptoms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance-related Disorders

Drugs mentioned

• Lorazepam (Lorazepam)
• pentobarbital (pentobarbital)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Substance-Related Disorders | Phase 1, Phase 2 | Status: WITHDRAWN